Careers  |  Sign In  |  Register  |   Twitter

Latest in Neurology & Neurosurgery

In a recent study, fluoxetine (Prozac) decreased progression of relapsing-remitting MS in a small placebo-controlled study, but the effect lasted only a few months. References and Resources Mostert J, et al. Effects of fluoxetine on disease activity in relapsing multiple sclerosis: A double-blind,...
A tablet that combines sumatriptan and naproxen (Treximet) has been approved by the FDA for treatment of migraine with and without aura. References and Resources FDA Sponsored by The Doctor's Channel
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, discusses current treatments for brain cancer. References and Resources Schönekaes K, Mücke R, Panke J, Rama B, Wagner W. Combined radiotherapy and temozolomide in patients with recurrent...